– Effort will sequence the genomes of 45,000 participants from across Ireland to identify novel targets and advance the clinical development of better treatments for a range of serious diseases – Focus is on key AbbVie therapeutic areas including oncology, neuroscience and immunology – Genomics Medicine Ireland will partner with Ireland’s leading clinicians and researchers […]
CROMWELL, Conn. & WINDSOR, Conn.–Biological Industries USA, Inc. (BI‐USA) and Rainbow Scientific, Inc. announced today a co‐promotion and sales agreement that grants Rainbow Scientific both promotion and sales rights to BI-USA’s range of cytogenetic products to the clinical laboratory market. “Rainbow Scientific has been a leading distributor to hospital laboratories, medical reference laboratories, and clinical […]
Structural Variant Detection, De Novo Assembly and Targeted Sequencing Applications Improved MENLO PARK, Calif. — Pacific Biosciences of California, Inc. (Nasdaq:PACB) today announced a new version of chemistry (V2) and software (V4) for the Sequel™ System. The new release improves the system’s ability to support important applications such as structural variant detection and targeted sequencing— including […]
WASHINGTON, D.C. MINNEAPOLIS, MN – The COPD Foundation-sponsored COPD Biomarker Qualification Consortium (CBQC) today announced that it has partnered with the Bio-Techne Corporation, a manufacturer of biotechnology products for life science research and diagnostics. The partnership was established to evaluate the suitability of a soluble form of receptor for advanced glycation end products (sRAGE) as a predictive biomarker […]
SAN DIEGO & HERCULES, Calif.– Illumina, Inc. (NASDAQ:ILMN) and Bio-Rad Laboratories, Inc. (NYSE:BIO) (NYSE:BIOb) today announced the launch of the Illumina® Bio-Rad® Single-Cell Sequencing Solution at the J.P. Morgan Healthcare Conference. The comprehensive solution is the first next-generation sequencing (NGS) workflow for single-cell analysis, providing researchers the ability to investigate the coordinated contribution of individual cells in tissue function, disease progression, and therapeutic response. […]
Data interpretation from Watson will help users translate genomic data from Illumina TruSight® Tumor 170; offering to be available early in 2017 SAN FRANCISCO – IBM Watson Health (NYSE:IBM) and Illumina, Inc. (NASDAQ:ILMN) today announced a groundbreaking partnership to expand access to genome data interpretation by integrating Watson for Genomics into Illumina’s BaseSpace Sequence Hub and tumor sequencing […]
Collaboration aims to leverage Illumina’s world-class DNA sequencing technology and BaseSpace Sequence Hub with Philips’ innovative cloud-based genomics platform for the acquisition, analysis and interpretation of genomics data in cancer research Amsterdam, the Netherlands, and San Diego, US – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Illumina, Inc.(NASDAQ:ILMN), the global leader in DNA […]
SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (NASDAQ:FLDM) today announced preliminary revenue for the fourth quarter and full year ended December 31, 2016. Total revenue for the fourth quarter of 2016 is expected to be in the range of approximately $24.7 million to $25.2 million based on preliminary, unaudited financial data. At the midpoint of the […]
Pall ForteBio acquires the Pioneer SPR Platform from SensiQ Technologies, expanding its portfolio of BLI-based biomolecular characterization instruments to include SPR-based small molecule fragment screening and more detailed biologics characterization. Freemont, CA Pall ForteBio, the developer and provider of industry-leading label-free biosensor technology platform, today announced that they will acquire the assets related to SensiQ’s […]
CINCINNATI — Bioline, The PCR Company, a wholly-owned subsidiary of Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced the expansion of the EPIK™ miRNA Select Assays, originally developed for the study of individual microRNA (miRNA) molecules. In collaboration with MiRXES, Bioline released 800 EPIK™ miRNA Select Assays in March 2016 and this has now been increased to include all of the organisms […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
